Cancer Research Cancer Genome no Abstract  CR Podcast
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 1109-1115, March 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ibrado, A. M.
Right arrow Articles by Bhalla, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ibrado, A. M.
Right arrow Articles by Bhalla, K.

Bcl-xL Overexpression Inhibits Progression of Molecular Events Leading to Paclitaxel-induced Apoptosis of Human Acute Myeloid Leukemia HL-60 Cells

Ana Maria Ibrado, Linda Liu and Kapil Bhalla1

Division of Hematology/Oncology, Department of Medicine, Winship Cancer Center, Emory University School of Medicine, Atlanta, Georgia 30322

Paclitaxel has been shown to activate Raf-1 and cause phosphorylation of Bcl-2, which has been correlated with paclitaxel-induced apoptosis of cancer cells. In the present studies, we demonstrate that in human AML HL-60 cells that express Bcl-2 but little Bcl-xL (HL-60/neo cells), paclitaxel-induced phosphorylation of Bcl-2 is followed by increased intracellular free Bax levels. This, in turn, is followed by the cleavage and activation of the key cysteine protease, CPP32ß/Yama, and cleavage of poly(ADP-ribose) polymerase, resulting in the DNA fragmentation of apoptosis. Cotreatment with the benzoquinone ansamycin Geldanamycin depleted Raf-1 but did not decrease Bcl-2 levels or impair paclitaxel-induced Bcl-2 phosphorylation in HL-60/neo cells. Also, Geldanamycin did not affect paclitaxel-induced apoptosis of HL-60/neo cells. As compared to the control HL-60/neo, HL-60/Bcl-xL cells contain Bcl-2 as well as an enforced overexpression of Bcl-xL. Immunoprecipitation studies with anti-Bcl-2 and/or anti-Bcl-x antibodies demonstrated that HL-60/Bcl-xL cells possess lower free Bax but higher levels of Bax heterodimerized to Bcl-2 and Bcl-xL. Following treatment of HL-60/Bcl-xL cells with paclitaxel, although Bcl-2 phosphorylation was observed, it was not followed by increased free Bax levels, cleavage of CPP32ß/Yama and poly(ADP-ribose) polymerase, or induction of the DNA fragmentation of apoptosis. These findings indicate the order of molecular events leading to paclitaxel-induced apoptosis and show that Raf-1 may not be involved in paclitaxel-induced phosphorylation of Bcl-2 or apoptosis of HL-60 cells.

1 To whom requests for reprints should be addressed, at Division of Hematology/Oncology, Emory University School of Medicine, Winship Cancer Center, 1365-B Clifton Road, N.E., Atlanta, GA 30322. Phone: (404) 778-3992; Fax (404) 778-3965.

Received 8/16/96. Accepted 1/14/97.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Upreti, E. N. Galitovskaya, R. Chu, A. J. Tackett, D. T. Terrano, S. Granell, and T. C. Chambers
Identification of the Major Phosphorylation Site in Bcl-xL Induced by Microtubule Inhibitors and Analysis of Its Functional Significance
J. Biol. Chem., December 19, 2008; 283(51): 35517 - 35525.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Haluska, J. M. Carboni, D. A. Loegering, F. Y. Lee, M. Wittman, M. G. Saulnier, D. B. Frennesson, K. R. Kalli, C. A. Conover, R. M. Attar, et al.
In vitro and In vivo Antitumor Effects of the Dual Insulin-Like Growth Factor-I/Insulin Receptor Inhibitor, BMS-554417
Cancer Res., January 1, 2006; 66(1): 362 - 371.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Wang, N. Li, H. Li, B. Liu, J. Qiu, T. Chen, and X. Cao
Silencing of Human Phosphatidylethanolamine-Binding Protein 4 Sensitizes Breast Cancer Cells to Tumor Necrosis Factor-{alpha}-Induced Apoptosis and Cell Growth Arrest
Clin. Cancer Res., October 15, 2005; 11(20): 7545 - 7553.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-J. Park, C.-H. Wu, J. D. Gordon, X. Zhong, A. Emami, and A. R. Safa
Taxol Induces Caspase-10-dependent Apoptosis
J. Biol. Chem., December 3, 2004; 279(49): 51057 - 51067.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y. Huang, Y. Fang, J. Wu, J. M. Dziadyk, X. Zhu, M. Sui, and W. Fan
Regulation of Vinca alkaloid-induced apoptosis by NF-{kappa}B/I{kappa}B pathway in human tumor cells
Mol. Cancer Ther., March 1, 2004; 3(3): 271 - 277.
[Abstract] [Full Text]


Home page
Molecular Cancer TherapeuticsHome page
A. R. Jazirehi and B. Bonavida
Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis
Mol. Cancer Ther., January 1, 2004; 3(1): 71 - 84.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
C. Ferlini, G. Raspaglio, S. Mozzetti, M. Distefano, F. Filippetti, E. Martinelli, G. Ferrandina, D. Gallo, F. O. Ranelletti, and G. Scambia
Bcl-2 Down-Regulation Is a Novel Mechanism of Paclitaxel Resistance
Mol. Pharmacol., July 1, 2003; 64(1): 51 - 58.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Wittmann, P. Bali, S. Donapaty, R. Nimmanapalli, F. Guo, H. Yamaguchi, M. Huang, R. Jove, H. G. Wang, and K. Bhalla
Flavopiridol Down-Regulates Antiapoptotic Proteins and Sensitizes Human Breast Cancer Cells to Epothilone B-induced Apoptosis
Cancer Res., January 1, 2003; 63(1): 93 - 99.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A C Okaro, D A Fennell, M Corbo, B R Davidson, and F E Cotter
Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-XL and Mcl-1 expressing human cholangiocarcinoma cells
Gut, October 1, 2002; 51(4): 556 - 561.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Mabuchi, M. Ohmichi, A. Kimura, K. Hisamoto, J. Hayakawa, Y. Nishio, K. Adachi, K. Takahashi, E. Arimoto-Ishida, Y. Nakatsuji, et al.
Inhibition of Phosphorylation of BAD and Raf-1 by Akt Sensitizes Human Ovarian Cancer Cells to Paclitaxel
J. Biol. Chem., August 30, 2002; 277(36): 33490 - 33500.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Stadheim, N. Suh, N. Ganju, M. B. Sporn, and A. Eastman
The Novel Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) Potently Enhances Apoptosis Induced by Tumor Necrosis Factor in Human Leukemia Cells
J. Biol. Chem., May 3, 2002; 277(19): 16448 - 16455.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Huisman, C. G. Ferreira, L. E. Broker, J. A. Rodriguez, E. F. Smit, P. E. Postmus, F. A. E. Kruyt, and G. Giaccone
Paclitaxel Triggers Cell Death Primarily via Caspase-independent Routes in the Non-Small Cell Lung Cancer Cell Line NCI-H460
Clin. Cancer Res., February 1, 2002; 8(2): 596 - 606.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Yamaguchi, S. R. Paranawithana, M. W. Lee, Z. Huang, K. N. Bhalla, and H.-G. Wang
Epothilone B Analogue (BMS-247550)-mediated Cytotoxicity through Induction of Bax Conformational Change in Human Breast Cancer Cells
Cancer Res., January 1, 2002; 62(2): 466 - 471.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Nimmanapalli, C. L. Perkins, M. Orlando, E. O’Bryan, D. Nguyen, and K. N. Bhalla
Pretreatment with Paclitaxel Enhances Apo-2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis of Prostate Cancer Cells by Inducing Death Receptors 4 and 5 Protein Levels
Cancer Res., January 1, 2001; 61(2): 759 - 763.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
Y. Huang, K. R. Johnson, J. S. Norris, and W. Fan
Nuclear Factor-{{kappa}}B/I{{kappa}}B Signaling Pathway May Contribute to the Mediation of Paclitaxel-induced Apoptosis in Solid Tumor Cells
Cancer Res., August 1, 2000; 60(16): 4426 - 4432.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
C. Gajate, I. Barasoain, J. M. Andreu, and F. Mollinedo
Induction of Apoptosis in Leukemic Cells by the Reversible Microtubule-disrupting Agent 2-Methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: Protection by Bcl-2 and Bcl-XL and Cell Cycle Arrest
Cancer Res., May 1, 2000; 60(10): 2651 - 2659.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
S.-C. J. Yeung, G. Xu, J. Pan, M. Christgen, and A. Bamiagis
Manumycin Enhances the Cytotoxic Effect of Paclitaxel on Anaplastic Thyroid Carcinoma Cells
Cancer Res., February 1, 2000; 60(3): 650 - 656.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
A. L. Johnson, J. T. Bridgham, and T. Jensen
Bcl-XLONG Protein Expression and Phosphorylation in Granulosa Cells
Endocrinology, October 1, 1999; 140(10): 4521 - 4529.
[Abstract] [Full Text]


Home page
JCOHome page
M. Monzo, R. Rosell, J. J. Sanchez, J. S. Lee, A. O'Brate, J. L. Gonzalez-Larriba, V. Alberola, J. C. Lorenzo, L. Nunez, J. Y. Ro, et al.
Paclitaxel Resistance in Non-Small-Cell Lung Cancer Associated With Beta-Tubulin Gene Mutations
J. Clin. Oncol., June 1, 1999; 17(6): 1786 - 1786.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W. Li, J. Fan, D. Banerjee, and J. R. Bertino
Overexpression of p21waf1 Decreases G2-M Arrest and Apoptosis Induced by Paclitaxel in Human Sarcoma Cells Lacking Both p53 and Functional Rb Protein
Mol. Pharmacol., June 1, 1999; 55(6): 1088 - 1093.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. J. Kottke, A. L. Blajeski, L. M. Martins, P. W. Mesner Jr., N. E. Davidson, W. C. Earnshaw, D. K. Armstrong, and S. H. Kaufmann
Comparison of Paclitaxel-, 5-Fluoro-2'-deoxyuridine-, and Epidermal Growth Factor (EGF)-induced Apoptosis. EVIDENCE FOR EGF-INDUCED ANOIKIS
J. Biol. Chem., May 28, 1999; 274(22): 15927 - 15936.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Gibson, C. Widmann, and G. L. Johnson
Differential Involvement of MEK Kinase 1 (MEKK1) in the Induction of Apoptosis in Response to Microtubule-targeted Drugs versus DNA Damaging Agents
J. Biol. Chem., April 16, 1999; 274(16): 10916 - 10922.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. D. Scatena, Z. A. Stewart, D. Mays, L. J. Tang, C. J. Keefer, S. D. Leach, and J. A. Pietenpol
Mitotic Phosphorylation of Bcl-2 during Normal Cell Cycle Progression and Taxol-induced Growth Arrest
J. Biol. Chem., November 13, 1998; 273(46): 30777 - 30784.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. M. Martins, T. J. Kottke, S. H. Kaufmann, and W. C. Earnshaw
Phosphorylated Forms of Activated Caspases Are Present in Cytosol From HL-60 Cells During Etoposide-Induced Apoptosis
Blood, November 1, 1998; 92(9): 3042 - 3049.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. E. Nesbit, S. Fan, H. Zhang, and E. V. Prochownik
Distinct Apoptotic Responses Imparted by c-myc and max
Blood, August 1, 1998; 92(3): 1003 - 1010.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-H. Ling, C. Tornos, and R. Perez-Soler
Phosphorylation of Bcl-2 Is a Marker of M Phase Events and Not a Determinant of Apoptosis
J. Biol. Chem., July 24, 1998; 273(30): 18984 - 18991.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.